Publication

New approaches to the endocrine prevention and treatment of breast cancer.

; ; 
Evans, D Gareth R
Citations
Altmetric:
Abstract
All major endocrine prevention approaches act via the estrogen receptor (ER). A simple hypothesis concerning ER expression and breast cancer risk is outlined. We review breast cancer prevention trials with tamoxifen, raloxifene, aromatase inhibitors, and ovarian suppression. Current and planned endocrine prevention trials in populations of pre- and postmenopausal women at risk of breast cancer are summarized and endocrine therapy after primary surgery and for advanced disease discussed.
Authors
Howell, Anthony
Howell, Sacha J
Evans, D Gareth R
Affiliation
CRUK Department of Medical Oncology, Christie Hospital NHS Trust, University of Manchester, Wilmslow Road, M20 4BX, Manchester, UK. maria.parker@christie-tr.nwest.nhs.uk
Description
Date
2003-07
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Breast Cancer
Type
Article
Citation
New approaches to the endocrine prevention and treatment of breast cancer. 2003, 52 Suppl 1:S39-44 Cancer Chemother. Pharmacol.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/78794
Embedded videos